Compare JBDI & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JBDI | EVGN |
|---|---|---|
| Founded | 1983 | 1999 |
| Country | Singapore | Israel |
| Employees | N/A | N/A |
| Industry | | Agricultural Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7M | 11.1M |
| IPO Year | 2023 | 2013 |
| Metric | JBDI | EVGN |
|---|---|---|
| Price | $1.38 | $0.55 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 39.3K | ★ 362.1K |
| Earning Date | 05-07-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $73.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.39 | $0.37 |
| 52 Week High | $2.28 | $1.50 |
| Indicator | JBDI | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 56.47 | 47.37 |
| Support Level | $1.13 | $0.53 |
| Resistance Level | $1.41 | $0.84 |
| Average True Range (ATR) | 0.12 | 0.07 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 72.73 | 3.74 |
JBDI Holdings Ltd is a supplier of Reconditioned and new Containers in Singapore. It's in the trading of reconditioned and recycling containers in Singapore and the Southeast Asia region. The company offers reconditioning and recycling drums, including open top drums, metal drums, plastic drums, plastic carboys, and intermediate bulk containers, as well as new drums, and collects waste drums and related products. It serves solvent, chemical, petroleum, and edible product oil industries.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.